Zoladex 3.6 MG implant syrns
Ended Awarded
- Contract number
- SPE2DX25F6UWS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,310
Award facts
- Contract value 100% obligated
- $3,309.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a $3,309.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zoladex 3.6 mg implant syringes. This non-set-aside competitive award was issued on September 12, 2025, with an ultimate completion date of October 3, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion ceiling value and extends through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with particular emphasis on supporting military and veteran healthcare systems. The $1 billion prime IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. Zoladex, a hormone-based treatment used primarily for prostate cancer and endometriosis management, represents one of many specialized pharmaceutical products the contractor delivers through its federal contract portfolio. The DLA has announced plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the key vendors supporting this strategic procurement initiative.
Quick answers
Who was awarded contract SPE2DX25F6UWS?
SPE2DX25F6UWS was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 12, 2025.
How much is contract SPE2DX25F6UWS worth?
The government has obligated $3,310 on SPE2DX25F6UWS.
Is contract SPE2DX25F6UWS an order under another contract?
Yes. SPE2DX25F6UWS is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6UWS competed?
The extent of competition for SPE2DX25F6UWS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award